甲状旁腺癌诊治

doi:10.16139/j.1007-9610.2018.02.006

外科理论与实践 ›› 2018, Vol. 23 ›› Issue (02): 112-115.doi: 10.16139/j.1007-9610.2018.02.006

甲状旁腺癌诊治

王雪薇, 王培松, 陈光

吉林大学白求恩第一医院甲状腺外科,吉林长春 130021

收稿日期:2018-01-08 出版日期:2018-03-25 发布日期:2020-07-25
通讯作者: 陈光,E-mail: cg9293@sina.com
基金资助:
吉林省自然科学基金（20180101138JC）

Received:2018-01-08 Online:2018-03-25 Published:2020-07-25

摘要/Abstract

中图分类号:

R736.2

王雪薇, 王培松, 陈光. 甲状旁腺癌诊治[J]. 外科理论与实践, 2018, 23(02): 112-115.

[1] Quervain FD.Parastruma maligna aberrata[J]. Deutsche Zeitschrift Fuer Chirurgie,1909,100(1):334-352.
[2] Armstrong HG.Primary carcinoma of parathyroid gland with report of case[J]. Bull Acad Med Toronto,1938:11:105-110.
[3] Sadler C, Gow KW, Beierle EA, et al.Parathyroid carcinoma in more than 1,000 patients: A population-level analysis[J]. Surgery,2014,156(6):1622-1629.
[4] Asare EA, Sturgeon C, Winchester DJ, et al.Parathyroid carcinoma: an update on treatment outcomes and prognostic factors from the National Cancer Data Base (NCDB)[J]. Ann Surg Oncol,2015,22(12):3990-3995.
[5] Schaapveld M, Jorna FH, Aben KK, et al.Incidence and prognosis of parathyroid gland carcinoma: a population-based study in the Netherlands estimating the preoperative diagnosis[J]. Am J Surg,2011,202(5):590-597.
[6] Hundahl SA, Fleming ID, Fremgen AM, et al.Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society[J]. Cancer,1999,86(3):538-544.
[7] 王培松, 薛帅, 王硕,等. 中国甲状旁腺癌234例分析[J]. 中华内分泌外科杂志,2017,11(4):334-337.
[8] 陈海珍, 薛松, 陈曦, 等. 甲状旁腺癌的诊断和治疗(附30例报告)[J]. 中国实用外科杂志,2014,34(4):324-328.
[9] Lee PK, Stephanie L. Jarosek RN, et al.Trends in the incidence and treatment of parathyroid cancer in the United States[J]. Cancer,2007,109(9):1736-1741.
[10] 王超华, 朱梅, 邱明才, 等. 多次复发甲状旁腺癌一例[J]. 天津医药,2011,39(5):478-479.
[11] Thakker RV.Genetics of parathyroid tumours[J]. J Intern Med,2016,280(6):574-583.
[12] Shattuck TM, Kim TS, Costa J, et al.Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma[J]. Clin Endocrinol,2003,59(2):180-189.
[13] Christmas TJ, Chapple CR, Noble JG, et al.Hyperparathyroidism after neck irradiation[J]. Br J Surg,1988, 75(9):873-874.
[14] Schantz A, Castleman B.Parathyroid carcinoma. A study of 70 cases[J]. Cancer,1973,31(3):600-605.
[15] Klink BK, Karulf RE, Maimon WN, et al.Nonfunctioning parathyroid carcinoma[J]. Am Surg,1991,57(7):463-467.
[16] 黎俊, 李莉, 林华. 99mTc-MIBI双时相显像与SPECT/CT融合显像对原发性甲状旁腺功能亢进症的诊断价值[J]. 医学影像学杂志,2017,27(6):1063-1067.
[17] Christakis I, Vu T, Chuang HH, et al.The diagnostic accuracy of neck ultrasound, 4D-computed tomographyand sestamibi imaging in parathyroid carcinoma[J]. Eur J Radiol,2017,95:82-88.
[18] Shi C, Guan H, Qi W, et al.Intrathyroidal parathyroid adenoma: Diagnostic pitfalls on fine-needle aspiration: Two case reports and literature review[J]. Diagn Cytopathol,2016,44(11):921-925.
[19] Kim J, Horowitz G, Hong M, et al.The dangers of parathyroid biopsy[J]. J Otolaryngol Head Neck Surg,2017,46(1):4.
[20] 王培松, 韩祎, 王硕, 等. PTH监测在原发性甲旁亢手术中的应用[J]. 中华内分泌外科杂志,2017,11(1):20-23.
[21] Truran PP, Johnson SJ, Bliss RD, et al.Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer[J]. World J Surg,2014,38(11):2845-2854.
[22] Uchida N, Ishiguro K, Suda T, et al.Metastatic breast tumor due to nonfunctional parathyroid carcinoma[J]. Inter Cancer Confer J,2011,1(1):47-52.
[23] Munson ND, Foote RL, Northcutt RC, et al.Parathyroid carcinoma: is there a role for adjuvant radiation therapy?[J]. Cancer,2003,98(11):2378-2384.
[24] Takeuchi Y, Takahashi S, Miura D, et al.Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism[J]. J Bone Miner Metab,2017,35(6):616-622.
[25] Horie I, Ando T, Inokuchi N, et al.First Japanese patient treated with parathyroid hormone peptide immunization for refractory hypercalcemia caused by metastatic parathyroid carcinoma[J]. Endocr J,2010,57(4):287-292.
[26] Fountas A, Andrikoula M, Giotaki Z, et al.The emerging role of denosumab in the long-term management of parathyroid carcinoma-related refractory hypercalcemia[J]. Endocr Pract,2015,21(5):468-473.
[27] Shaha AR, Shah JP.Parathyroid carcinoma: a diagnostic and therapeutic challenge[J]. Cancer,1999,86(3):378-380.
[28] Talat N, Schulte KM.Clinical presentation, staging and long-term evolution of parathyroid cancer[J]. Ann Surg Oncol,2010,17(8):2156-2174.
[29] Schulte KM, Gill AJ, Barczynski M, et al.Classification of parathyroid cancer[J]. Ann Surg Oncol,2012,19(8):2620-2628.

甲状旁腺癌诊治

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	冯国伟, 陈刚. ^99mTc-MIBI SPECT/CT甲状旁腺显像发现颈部恶性肿瘤的价值及与超声对比[J]. 诊断学理论与实践, 2018, 17(06): 682-686.
[2]	王红鹰, 黄骏文, 邹强, 陈靖, 张敏敏, 张炜晨, 劳正胤. 甲状旁腺全切除加前臂自体移植术治疗肾性继发性甲状旁腺功能亢进的长期疗效[J]. 外科理论与实践, 2018, 23(06): 523-527.
[3]	廖泉. 多科合作诊治甲状旁腺功能亢进症[J]. 外科理论与实践, 2018, 23(02): 93-95.
[4]	王义增, 何向辉. 原发性甲状旁腺功能亢进症的术前与术中定位[J]. 外科理论与实践, 2018, 23(02): 116-119.
[5]	李富新, 姜若愚, 李东洋, 陈作宇, 魏铭泽, 张柏, 何向辉. 原发性甲状旁腺功能亢进症临床分析（附138例报告）[J]. 外科理论与实践, 2018, 23(02): 125-129.
[6]	贺青卿, 周鹏, 庄大勇, 朱见, 范子义, 郑鲁明, 岳涛, 王猛, 王丹, 李小磊. 达芬奇机器人辅助外科治疗原发性甲状旁腺功能亢进[J]. 外科理论与实践, 2018, 23(02): 130-134.
[7]	仝海磊, 王培松, 孟伟. 热消融治疗继发性甲状旁腺功能亢进[J]. 外科理论与实践, 2018, 23(02): 166-168.
[8]	陈海珍, 陈曦. 肾性继发性甲状旁腺功能亢进症的多学科协作治疗[J]. 外科理论与实践, 2018, 23(02): 103-107.
[9]	杜海磊, 朱良纲, 车嘉铭, 任健, 邱维诚, 杭钧彪, 陈中元, 李鹤成,. 纵隔异位甲状旁腺的外科治疗[J]. 外科理论与实践, 2016, 21(04): 318-320.
[10]	陈俏峰, 黄循波, 王天翔,. 甲状旁腺肿瘤临床分析(附16例报告)[J]. 外科理论与实践, 2012, 17(05): 494-496.
[11]	邓艳华, 刘建民,. 甲状旁腺良恶性肿瘤的鉴别[J]. 诊断学理论与实践, 2010, 9(06): 622-624.
[12]	仇明,. 微创手术切除甲状腺及甲状旁腺病灶的关键技术[J]. 外科理论与实践, 2009, 14(04): 385-388.
[13]	郭伯敏, 樊友本,. 甲状旁腺瘤的内镜手术治疗进展[J]. 外科理论与实践, 2009, 14(01): 111-114.
[14]	贺晓燕, 韩晴, 陈曦, 刘建民, 宁光,. 160例原发性甲状旁腺功能亢进症患者临床资料初步分析[J]. 诊断学理论与实践, 2007, 6(03): 243-247.
[15]	刘建民,. 高钙血症的病因分析及其鉴别诊断思路[J]. 诊断学理论与实践, 2006, 5(06): 474-476.